Allogeneic hsct graft allogeneic stem cell transplantation. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy33

Stem Cells Hematopoietic Stem Cells Antilymphocyte Serum T-Lymphocytes Embryonic Stem Cells Adult Stem Cells Bone Marrow Cells CD8-Positive T-Lymphocytes Pluripotent Stem Cells Cells, Cultured Bone Marrow Mesenchymal Stromal Cells T-Lymphocytes, Cytotoxic Neural Stem Cells Induced Pluripotent Stem Cells Philadelphia Chromosome CD4-Positive T-Lymphocytes Killer Cells, Natural Lymphocytes Multipotent Stem Cells Fetal Blood T-Lymphocyte Subsets T-Lymphocytes, Regulatory Fetal Stem Cells Allografts Dendritic Cells Spleen Blood Cells B-Lymphocytes Thymus Gland Spermatogonia Transplants Neoplastic Stem Cells

Organisms9

Transplantation Chimera Cytomegalovirus Herpesvirus 6, Human Mice, Inbred C57BL Mice, Inbred BALB C Herpesvirus 4, Human Radiation Chimera Chimera Mice, SCID

Diseases46

Graft vs Host Disease Hematologic Neoplasms Recurrence Leukemia Leukemia, Myeloid, Acute Multiple Myeloma Leukemia, Myelogenous, Chronic, BCR-ABL Positive Cytomegalovirus Infections Acute Disease Myelodysplastic Syndromes Precursor Cell Lymphoblastic Leukemia-Lymphoma Neoplasm, Residual Hepatic Veno-Occlusive Disease Anemia, Aplastic Hematologic Diseases Primary Myelofibrosis Leukemia, Myeloid, Accelerated Phase Roseolovirus Infections Leukemia, Myeloid Lymphoproliferative Disorders Hodgkin Disease Infection Lymphoma, Non-Hodgkin Opportunistic Infections Stomatitis Mycoses Adenoviridae Infections Lymphoma Leukemia, Lymphocytic, Chronic, B-Cell Chronic Disease Blast Crisis Epstein-Barr Virus Infections Lymphoma, Follicular Aspergillosis Philadelphia Chromosome Viremia Neoplasms Neoplasm Recurrence, Local Severe Combined Immunodeficiency Disease Progression Graft Occlusion, Vascular Postoperative Complications Lymphoma, Mantle-Cell Blood Group Incompatibility Disease Models, Animal Iron Overload

Chemicals and Drugs49

Myeloablative Agonists Busulfan Vidarabine Immunosuppressive Agents Minor Histocompatibility Antigens Antilymphocyte Serum Melphalan Cyclophosphamide HLA Antigens Antigens, CD34 Antibodies, Neoplasm Cytarabine Benzamides Antineoplastic Agents Fusion Proteins, bcr-abl Cyclosporine Receptors, Purinergic P2X5 Pyrimidines Ganciclovir Granulocyte Colony-Stimulating Factor Piperazines Antibodies, Monoclonal Antibodies, Monoclonal, Murine-Derived Etoposide Antigens, CD Benzydamine Antiviral Agents Isoantigens Vincristine Antibodies, Monoclonal, Humanized Antigens, Viral Stem Cell Factor Viral Matrix Proteins DNA, Viral Cytokines Carmustine fms-Like Tyrosine Kinase 3 Tacrolimus Antigens, Neoplasm Thiotepa Interferon-gamma Antineoplastic Agents, Alkylating Biological Markers Thalidomide HLA-A2 Antigen Antifungal Agents Methotrexate Prednisone Isoantibodies

Analytical, Diagnostic and Therapeutic Techniques and Equipment83

Hematopoietic Stem Cell Transplantation Transplantation, Homologous Stem Cell Transplantation Transplantation Conditioning Transplantation, Autologous Peripheral Blood Stem Cell Transplantation Treatment Outcome Bone Marrow Transplantation Remission Induction Retrospective Studies Histocompatibility Testing Lymphocyte Transfusion Survival Rate Whole-Body Irradiation Cord Blood Stem Cell Transplantation Combined Modality Therapy Lymphocyte Depletion Salvage Therapy Liver Transplantation Survival Analysis Disease-Free Survival Follow-Up Studies Hematopoietic Stem Cell Mobilization Antineoplastic Combined Chemotherapy Protocols Mesenchymal Stem Cell Transplantation Kidney Transplantation Cell Transplantation Immunosuppression Prognosis Risk Factors Prospective Studies Transplantation, Isogeneic Immunotherapy, Adoptive Heart Transplantation Leukocyte Transfusion Fatal Outcome Flow Cytometry Lymphocyte Count Immunotherapy Lung Transplantation Actuarial Analysis Islets of Langerhans Transplantation Immunophenotyping Polymerase Chain Reaction Organ Transplantation Transplantation Incidence Cytogenetic Analysis Cohort Studies Clinical Trials as Topic Cell Separation Lymphocyte Activation Lymphocyte Culture Test, Mixed Kaplan-Meier Estimate Feasibility Studies Skin Transplantation Reverse Transcriptase Polymerase Chain Reaction Donor Selection Leukapheresis Multivariate Analysis Transplantation, Heterotopic Pancreas Transplantation Transplantation, Heterologous Viral Load Pilot Projects Drug Evaluation Fetal Tissue Transplantation Life Tables Cell Culture Techniques Predictive Value of Tests Bone Marrow Purging Stem Cell Research Blood Transfusion, Autologous Blood Component Removal Disease Models, Animal Platelet Transfusion Cell- and Tissue-Based Therapy Graft Enhancement, Immunologic Risk Assessment Case-Control Studies Cell Count Coculture Techniques Treatment Failure

Psychiatry and Psychology2

Siblings Nuclear Family

Phenomena and Processes31

Graft vs Leukemia Effect Graft vs Tumor Effect Graft Survival Time Factors Histocompatibility Virus Activation Chimerism Transplantation Immunology Immunocompromised Host Graft Rejection Cell Differentiation Lymphocyte Count Stem Cell Niche Transplantation Tolerance Cell Proliferation T-Cell Antigen Receptor Specificity Hematopoiesis Philadelphia Chromosome Cytotoxicity, Immunologic Lymphocyte Activation Cell Lineage Graft vs Host Reaction Viral Load Regeneration Radiation Chimera Drug Resistance, Neoplasm Immune Tolerance Karyotype Host vs Graft Reaction Cell Count Cell Survival

Disciplines and Occupations2

Hematology Stem Cell Research

Anthropology, Education, Sociology and Social Phenomena2

Siblings Nuclear Family

Information Science4

Survival Rate Fatal Outcome Incidence Life Tables

Named Groups5

Tissue Donors Siblings Living Donors Blood Donors Unrelated Donors

Health Care24

Treatment Outcome Retrospective Studies Survival Rate Survival Analysis Disease-Free Survival Follow-Up Studies Risk Factors Prospective Studies Fatal Outcome Actuarial Analysis Incidence Cohort Studies Clinical Trials as Topic Kaplan-Meier Estimate Feasibility Studies Donor Selection Multivariate Analysis Pilot Projects Life Tables Predictive Value of Tests Risk Assessment Tissue and Organ Procurement Case-Control Studies Treatment Failure

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Information Science Named Groups Health Care Geographicals

Hematopoietic Stem Cell Transplantation Transplantation, Homologous Stem Cell Transplantation Graft vs Host Disease Transplantation Conditioning Hematologic Neoplasms Transplantation, Autologous Peripheral Blood Stem Cell Transplantation Graft vs Leukemia Effect Transplantation Chimera Treatment Outcome Graft vs Tumor Effect Bone Marrow Transplantation Stem Cells Graft Survival Recurrence Myeloablative Agonists Tissue Donors Busulfan Leukemia Remission Induction Vidarabine Retrospective Studies Histocompatibility Testing Immunosuppressive Agents Leukemia, Myeloid, Acute Lymphocyte Transfusion Survival Rate Multiple Myeloma Leukemia, Myelogenous, Chronic, BCR-ABL Positive Cytomegalovirus Infections Siblings Whole-Body Irradiation Cord Blood Stem Cell Transplantation Combined Modality Therapy Minor Histocompatibility Antigens Time Factors Hematopoietic Stem Cells Lymphocyte Depletion Salvage Therapy Histocompatibility Liver Transplantation Survival Analysis Antilymphocyte Serum Acute Disease Myelodysplastic Syndromes Disease-Free Survival Precursor Cell Lymphoblastic Leukemia-Lymphoma Virus Activation Neoplasm, Residual Chimerism Follow-Up Studies T-Lymphocytes Hepatic Veno-Occlusive Disease Melphalan Cyclophosphamide Cytomegalovirus Hematopoietic Stem Cell Mobilization Antineoplastic Combined Chemotherapy Protocols Mesenchymal Stem Cell Transplantation Anemia, Aplastic Kidney Transplantation HLA Antigens Transplantation Immunology Cell Transplantation Hematologic Diseases Primary Myelofibrosis Immunosuppression Prognosis Antigens, CD34 Leukemia, Myeloid, Accelerated Phase Embryonic Stem Cells Antibodies, Neoplasm Risk Factors Roseolovirus Infections Prospective Studies Leukemia, Myeloid Cytarabine Lymphoproliferative Disorders Immunocompromised Host Graft Rejection Transplantation, Isogeneic Benzamides Antineoplastic Agents Adult Stem Cells Fusion Proteins, bcr-abl Hodgkin Disease Cyclosporine Nuclear Family Receptors, Purinergic P2X5 Pyrimidines Ganciclovir Infection Immunotherapy, Adoptive Heart Transplantation Granulocyte Colony-Stimulating Factor Leukocyte Transfusion Lymphoma, Non-Hodgkin Living Donors Fatal Outcome

No FAQ available that match "allogeneic hsct graft allogeneic stem cell transplantation"